Dr Thomas Joudinaud, MD

Thomas has broad experience in healthcare ranging from practicing medicine to research, development and commercialization of therapeutics. He is a Cardio-vascular Thoracic surgeon by training and have more than 10 years of strategy consulting experience specialized in healthcare. Today, Thomas is CEO of Ceres-Brain Therapeutics, a biotech company spin-off from the CEA, and specialized in …

Dr Christian Pradeyrol, MD

Dr PRADEYROL is the Executive Chairman and Founder of Pradeyrol Développement, a family office actively investing in new technologies. With participations in a dozen of Biotech companies in France and in the US, Pradeyrol Développement is highly interested in immunology and preventive medicines, in vaccines, drugs and diagnostics. Prior experience: • Chairman and CEO, IMAXIO …

Dr Frédéric Schynts, PhD

Frédéric is a scientist with Virology, Immunology and Vaccinology background, experienced in vaccine, cell and gene therapy development from R&D to clinical phase, Business Development and Company Development strategy. Continuous learning and training on the Managerial and Entrepreneurial aspect of the Biotech Industry. Prior experience: • Investment Manager, Noshaq (2020-Present) • Independent Consultant (Schynts Consulting, …

Dr Chris Martin, PhD

Chris has over 20 years of experience in the pharmaceutical and biotech sector. He is an accomplished company founder and Director who has successfully brought technology from the lab to regulatory approval and global markets. Prior experience: • Chairman of the Board, Tokamak Energy Ltd (2015-current) • Co-founder and CEO, ADC Therapeutics (2012 – 2022) …

Florian Sourd

Florian has over 10 years of experience in corporate finance and financial services. Florian was involved more specifically in healthcare transactions for diagnostic companies and healthcare provider group. Prior experience: • Manager in Transaction Services, Deloitte (2015-2019) • Chief Financial Officer, OnyxT+ (2014-2015) • Senior in Financial Audit, EY (2012-2014) • M&A Analyst, BNP Paribas …

Vincent Bille, PhD

Vincent holds a track record of supporting biotech and pharmaceutical companies, providing his expertise in global process industrialization. Overall, Vincent brings over 30 years of experience in externalized operations relationship management, process development and scale-up, manufacturing, and technology transfer management of complex therapeutic biomolecules. Prior Experience: • Founder Marble Pharma Consult, Independent Consultant (2007 – …

Linda Lebon

Linda has more than 25 years of experience in developing and implementing regulatory strategy for EU and US for different types of products including biotech and various therapeutic area. Her knowledge of drug development and regulatory matters is enhanced by her understanding of the challenges with which pharmaceutical companies are confronted in their effort to …

Dr. Delphine Guyon-Gellin, DVM

Delphine has 15 years experience in vaccines business and strategy working as strategic consultant for leading pharmaceutical companies to help them solve their key challenges, along with an in-depth expertise in strategy for vaccines Prior experience: • Project leader, Boston Consulting Group, London (2014-2017) • Senior Consultant, Boston Consulting Group, Paris (2011-2014) • Junior Consultant, …

Dr Nicola Groth, MD

Nicola has 25 years of experience in vaccine development with considerable expertise in influenza vaccines. Through her various strategic positions in the industry, she has developed expertise throughout the vaccine lifecycle, including close and extensive interactions with regulatory agencies. Prior Experience: • Global Head of Safety Evaluation & Risk Management, GlaxoSmithKline (GSK) Vaccines, Siena (2015-2023) …

Dr Florence Nicolas, PhD

Florence has more than 25 years of experience in the development of biological products, vaccines and delivery systems, in particular in the areas of CMC, pharmacology, preclinical studies and preparation of regulatory documents for clinical trial application. Florence is also the Head of the influenza vaccine program. She also holds extensive experience in project and …